Journal article

Bridging the Osteoporosis Treatment Gap: Performance and Cost-Effectiveness of a Fracture Liaison Service

Christopher J Yates, Marie-Anne Chauchard, Danny Liew, Andrew Bucknill, John D Wark



Individuals who sustain fragility fractures are at high risk of refracture. However, osteoporosis treatment rates remain low for these patients. Therefore, we aimed to assess the performance and cost-effectiveness of introducing a fracture liaison service (FLS) into a tertiary hospital. In "nonhospitalized" ambulatory patients who had sustained fragility fractures, we assessed baseline osteoporosis investigation and treatment rates, and subsequently, the impact of introducing an orthopedic osteoporosis policy and an FLS. Outcomes measured were uptake of osteoporosis intervention, patient satisfaction, and quality-adjusted life years (QALYs) gained. QALYs were calculated over 5 years using pr..

View full abstract


Funding Acknowledgements

The authors thank Mr. Richard Farrugia for coordinating the referral of patients to the Fracture Capture Service, and Professor Tuan Nguyen and the Garvan Institute of Medical Research for use of the Garvan Fracture Risk Calculator. The research was funded by a grant from Servier Laboratories Australia. Marie-Anne Chauchard has received a grant-in-aid from Servier Laboratories. Christopher James Yates has received speaker fees and conference travel support from Servier Laboratories. Danny Liew has no disclosures relevant to this publication. Andrew Bucknill has no disclosures relevant to this publication. John D Wark in the past 5 years has received speaker fees and/or consultancy fees from Amgen, Eli Lilly, Novartis, Sanofi, Servier Laboratories. He has also received conference travel assistance from Servier Laboratories and research grants from Eli Lilly, Novartis, and Sanofi.